FDA Investigator Dinesh Kumar
Dinesh Kumar has conducted inspections on 2 sites in 2 countries as of 17 Feb 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
17 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Japan,
United States of America
FDA Investigators that have inspected at least one site in common with Dinesh Kumar:
Alberto A Viciedo,
Ann Marie Montemurro,
Cynthia Jim, CSO,
Douglas C Kovacs,
Emmanuel Jramos Maldonado,
Erin D Mccaffery,
Frank Wackes,
George J Flynn,
Gianine E Tompkins,
Guerlain Ulysse,
Haitao Li,
Helen Verdel,
Jawaid Hamid,
Jogy George,
Jose M Cayuela,
Joy Rkozlowski Klena,
Karen E D'orazio,
Larry K Austin,
Lucas B Leake,
Maotang Zhou, PhD,
Matthew A Spataro,
Matthew B Casale,
Melissa T Roy,
Michael R Klapal,
Nancy F Scheraga,
Niketa Patel,
Paul L Bellamy,
Richard E Needham,
Richard W Thornton,
Robin P Mathew,
Sidney B Priesmeyer,
Stephen D Brown,
Tamil Arasu, PhD,
Unnee Ranjan,
Zakaria I Ganiyu,
Zhijin Chen
Dinesh Kumar's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2014 | FDA 483 | Halo Pharmaceuticals Inc. - Form 483, 2014-05-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more